paper-with-me

홈 › Papers

Generating 3D Molecules Conditional on Receptor Binding Sites with Deep Generative Models

2021-10-28 · Matthew Ragoza, Tomohide Masuda, David Ryan Koes

The goal of structure-based drug discovery is to find small molecules that bind to a given target protein. Deep learning has been used to generate drug-like molecules with certain cheminformatic properties, but has not yet been applied to generating 3D molecules predicted to bind to proteins by sampling the conditional distribution of protein-ligand binding interactions. In this work, we describe for the first time a deep learning system for generating 3D molecular structures conditioned on a receptor binding site. We approach the problem using a conditional variational autoencoder trained on an atomic density grid representation of cross-docked protein-ligand structures. We apply atom fitting and bond inference procedures to construct valid molecular conformations from generated atomic densities. We evaluate the properties of the generated molecules and demonstrate that they change significantly when conditioned on mutated receptors. We also explore the latent space learned by our generative model using sampling and interpolation techniques. This work opens the door for end-to-end prediction of stable bioactive molecules from protein structures with deep learning.

📄 PDF Abstract BibTeX arXiv:2110.15200

Code (2)

mattragoza/liGAN 공식 구현 caffe2
guanjq/targetdiff pytorch

Tasks

Deep LearningDrug Discoveryvalid

Similar Papers 제목 키워드 기반

Generating 3D Molecular Structures Conditional on a Receptor Binding Site with Deep Generative Models

2020-10-16 · Tomohide Masuda, Matthew Ragoza, David Ryan Koes

Deep generative models have been applied with increasing success to the generation of two dimensional molecules as SMILES strings and molecular graphs. In this work we describe for the first time a deep generative model …

Decodervalid

Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

2026-07-14 · Ruoxi Gao, Jiangweizhi Peng, Ziqi Chen, Frazier N. Baker 외 arxiv

Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD…

Representation LearningDrug Discovery

Revising Berg-Purcell for finite receptor kinetics

2021-01-15 · Gregory Handy, Sean D Lawley

From nutrient uptake, to chemoreception, to synaptic transmission, many systems in cell biology depend on molecules diffusing and binding to membrane receptors. Mathematical analysis of such systems often neglects the fa…

valid

A unified cross-attention model for predicting antigen binding specificity to both HLA and TCR molecules

2024-04-08 · Chenpeng Yu, Xing Fang, Hui Liu

The immune checkpoint inhibitors have demonstrated promising clinical efficacy across various tumor types, yet the percentage of patients who benefit from them remains low. The bindings between tumor antigens and HLA-I/T…

Specificity

DeepPocket: Ligand Binding Site Detection and Segmentation using 3D Convolutional Neural Networks

2021-08-10 · Journal of Chemical Information and Modeling 2021 8 · Rishal Aggarwal, Akash Gupta, Vineeth Chelur, C. V. Jawahar 외

A structure-based drug design pipeline involves the development of potential drug molecules or ligands that form stable complexes with a given receptor at its binding site. A prerequisite to this is finding druggable and…

Drug Design